189,460 Shares in The Joint Corp. $JYNT Bought by Clayton Partners LLC

Clayton Partners LLC acquired a new position in shares of The Joint Corp. (NASDAQ:JYNT) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 189,460 shares of the company’s stock, valued at approximately $1,652,000. Joint accounts for about 1.2% of Clayton Partners LLC’s holdings, making the stock its 29th largest holding.

Several other large investors have also modified their holdings of the company. BNP Paribas Financial Markets boosted its holdings in Joint by 104.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,935 shares of the company’s stock valued at $28,000 after purchasing an additional 1,501 shares during the period. JPMorgan Chase & Co. boosted its holdings in Joint by 32.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 7,412 shares of the company’s stock valued at $86,000 after purchasing an additional 1,810 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Joint by 25.9% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,244 shares of the company’s stock valued at $95,000 after purchasing an additional 1,698 shares during the period. Wells Fargo & Company MN boosted its holdings in Joint by 78.0% in the 4th quarter. Wells Fargo & Company MN now owns 15,476 shares of the company’s stock valued at $135,000 after purchasing an additional 6,784 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its holdings in Joint by 28.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 26,504 shares of the company’s stock valued at $232,000 after purchasing an additional 5,800 shares during the period. 76.88% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on JYNT shares. Wall Street Zen downgraded shares of Joint from a “strong-buy” rating to a “buy” rating in a report on Sunday, June 7th. Weiss Ratings raised shares of Joint from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, June 12th. Finally, Zacks Research raised shares of Joint from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 12th. One research analyst has rated the stock with a Strong Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $18.00.

Joint Stock Performance

NASDAQ:JYNT opened at $9.12 on Thursday. The company has a 50-day moving average of $8.80 and a 200-day moving average of $8.92. The company has a market capitalization of $130.05 million, a price-to-earnings ratio of 39.65 and a beta of 1.12. The Joint Corp. has a 52 week low of $7.50 and a 52 week high of $13.00.

Joint (NASDAQ:JYNT) last released its quarterly earnings data on Thursday, May 7th. The company reported $0.08 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.05. The company had revenue of $14.82 million during the quarter, compared to the consensus estimate of $14.50 million. Joint had a net margin of 5.72% and a return on equity of 7.00%. Sell-side analysts forecast that The Joint Corp. will post 0.51 EPS for the current year.

Insider Activity at Joint

In other Joint news, major shareholder Charles E. Jobson acquired 127,676 shares of Joint stock in a transaction dated Tuesday, May 12th. The stock was bought at an average cost of $8.57 per share, with a total value of $1,094,183.32. Following the acquisition, the insider owned 1,773,479 shares of the company’s stock, valued at approximately $15,198,715.03. The trade was a 7.76% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 30.20% of the company’s stock.

Joint Company Profile

The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics.